Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Alveron Pharma develops a drug, OKL-1111, to treat intracranial haemorrhage by reversing the effects of anticoagulants and platelet inhibitors.

Gradient Denervation Technologies is a medical device company that develops an ultrasound-based catheter device for the treatment of pulmonary hypertension.